Welcome to the Exeter Clinical Laboratory International website
NHS logo


Clinical Genetics Genomics


Porencephaly is defined as a cavity in the cerebral parenchyma that results in hemiplegia, hydrocephalus, epilepsy, mental retardation with poor/absent speech, dystonia and optic and pituitary defects. Cerebral haemorrhage/stroke in affected individuals can happen in the fetal period, in childhood or in adulthood.  COL4A1 and COL4A2 disease-causing variants have been reported in families with autosomal dominant porencephaly (Gould et al 2005 Science 308(5725), 1167-1171van der Knaap et al 2006 Ann Neurol 59(3), 504-511Breedveld et al 2006 J Med Genet 43(6), 490-495Yoneda et al 2012 Am J Hum Genet 90, 86-90).

A much wider phenotype HANAC (Hereditary Angiopathy, Nephropathy, Aneurysms, and muscle Cramps) syndrome has also been described (Plaisier et al 2007 N Engl J Med 357(26), 2687-2695) and Brain Small-vessel Disease with Hemorrhage, as well as a muscle-eye-brain disease phenotype (Labelle-Dumais et al 2011 PLoS Genet 7(5), e1002062)

The laboratory participates in the European Molecular Genetics Quality Network (EMQN) sequencing scheme.

University of Exeter logo
UKAS Medical logo


Royal Devon University Healthcare logo